161 related articles for article (PubMed ID: 1353673)
1. Neuroleptic prescription for Chinese schizophrenics in Hong Kong.
Chiu H; Lee S; Leung CM; Wing YK
Aust N Z J Psychiatry; 1992 Jun; 26(2):262-4. PubMed ID: 1353673
[TBL] [Abstract][Full Text] [Related]
2. A survey of antipsychotic treatment for schizophrenia in Hong Kong.
Yip KC; Ungvari GS; Cheung HK; Ng FS; Lau ST
Chin Med J (Engl); 1997 Oct; 110(10):792-6. PubMed ID: 9642312
[TBL] [Abstract][Full Text] [Related]
3. Psychotropic drug prescribing to chronic schizophrenics in a Hong Kong hospital.
Chiu HF; Shum PS; Lam CW
Int J Soc Psychiatry; 1991; 37(3):187-91. PubMed ID: 1743903
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
[TBL] [Abstract][Full Text] [Related]
5. Ideal and reality of neuroleptic relapse prevention.
Kissling W
Br J Psychiatry Suppl; 1992 Oct; (18):133-9. PubMed ID: 1356363
[No Abstract] [Full Text] [Related]
6. Neuroleptic dosing in Hispanic and Asian Inpatients with schizophrenia.
Collazo Y; Tam R; Sramek J; Herrera J
Mt Sinai J Med; 1996; 63(5-6):310-3. PubMed ID: 8898533
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic drug utilisation for acute schizophrenia.
Razali MS; Hasanah CI
Singapore Med J; 1996 Dec; 37(6):611-3. PubMed ID: 9104062
[TBL] [Abstract][Full Text] [Related]
8. Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia.
Xiang YT; Weng YZ; Leung CM; Tang WK; Sandor UG
Hum Psychopharmacol; 2007 Apr; 22(3):173-80. PubMed ID: 17397098
[TBL] [Abstract][Full Text] [Related]
9. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
Reschke RW
Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
[TBL] [Abstract][Full Text] [Related]
10. Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia.
Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
Pharmacopsychiatry; 2007 Mar; 40(2):47-52. PubMed ID: 17447172
[TBL] [Abstract][Full Text] [Related]
11. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
Kopala LC; Fredrikson D; Good KP; Honer WG
Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
[No Abstract] [Full Text] [Related]
12. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
Sramek JJ; Simpson GM; Morrison RL; Heiser JF
J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
[TBL] [Abstract][Full Text] [Related]
13. [Drug management and therapy resistance. A cross-sectional study of schizophrenic patients in a large psychiatric hospital].
Mohr F; Bender W; Hubmann W; Mäsel K; Pior R
Psychiatr Prax; 1992 Jul; 19(4):108-13. PubMed ID: 1354878
[TBL] [Abstract][Full Text] [Related]
14. Systematic dosage reduction in treatment-resistant schizophrenic patients.
Van Putten T; Marshall BD; Liberman R; Mintz J; Kuehnel TG; Bowen L; Aravagiri M; Marder SR
Psychopharmacol Bull; 1993; 29(2):315-20. PubMed ID: 7904763
[TBL] [Abstract][Full Text] [Related]
15. Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore.
Sim K; Su A; Chan YH; Shinfuku N; Kua EH; Tan CH
Psychiatry Clin Neurosci; 2004 Jun; 58(3):324-9. PubMed ID: 15149301
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic dosing in Asian and Hispanic outpatients with schizophrenia.
Ruiz S; Chu P; Sramek J; Rotavu E; Herrera J
Mt Sinai J Med; 1996; 63(5-6):306-9. PubMed ID: 8898532
[TBL] [Abstract][Full Text] [Related]
17. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
Chouinard G; Safadi G; Beauclair L
J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
[TBL] [Abstract][Full Text] [Related]
18. Clinical and social determinants of long-term use of benzodiazepines and its impact on quality of life of Chinese schizophrenia patients.
Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
Pharmacopsychiatry; 2007 Nov; 40(6):269-74. PubMed ID: 18030651
[TBL] [Abstract][Full Text] [Related]
19. [The "neuroleptic threshold"--a review of the literature].
Abraham D; Kissling W; Lauter H
Psychiatr Prax; 1996 May; 23(3):109-16. PubMed ID: 8710999
[TBL] [Abstract][Full Text] [Related]
20. Effective clinical response at low plasma levels of haloperidol in Japanese schizophrenics with acute psychotic state.
Jibiki I; Kubota T; Fujimoto K; Sakamoto H; Hasegawa M; Furuta H; Yamaguchi N
Jpn J Psychiatry Neurol; 1993 Sep; 47(3):627-9. PubMed ID: 8301878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
